APOA1 and cardiovascular disorder: Above-mentioned polymorphisms can influence on plasma lipids levels, such as HDL, LDL, ApoA1 concentration, triglycerides, total cholesterol and Lp(a), which changes in concentrations are recognized as risk factors of cardiovascular diseases.